ABOUT INTEGRAL MOLECULAR

Integral Molecular is a research-driven biotechnology company creating innovative technologies and therapeutic antibodies for under-exploited membrane protein targets, including GPCRs, ion channels, transporters, and viral envelopes.

September 21, 2016

Integral Molecular Launches Target Specificity Technology to Improve Safety of Biotherapeutics

Integral Molecular announces the launch of the Membrane Proteome Array (MPA), a rapid and reliable platform for de-risking therapeutic development by profiling the target specificity of […]
August 25, 2016

Integral Molecular Announces Breakthrough in Understanding the Functionality of GPCRs, the Largest Class of Drug Targets in Human Disease

Philadelphia, PA–(BUSINESS WIRE)–Integral Molecular, an industry leader in membrane protein antibody discovery, has announced a major advancement in understanding the functionality of G protein-coupled receptors (GPCRs), […]
May 26, 2016

Integral Molecular Develops B-Cell Cloning Technology to Discover Rare Antibodies against Membrane Proteins

Integral Molecular, a leader in antibody discovery, announces the development of an ultra high-throughput microfluidic B-cell cloning technology that can interrogate tens of millions of immune […]
February 10, 2016

Integral Molecular Expands Intellectual Property Landscape with International Patents Protecting Key Lipoparticle technology

Integral Molecular, a leader in membrane protein antibody discovery, has announced the issuance of two key patents in Europe and the U.S., strengthening the company’s rapidly […]
December 11, 2015

DNA Immunization Expert Dr. Ross Chambers Joins Integral Molecular to Lead Antibody Discovery

Integral Molecular, a leader in membrane protein antibody discovery, announced today the appointment of DNA immunization expert Ross Chambers, Ph.D., as Director of Antibody Discovery. Dr. […]
November 12, 2015

Integral Molecular Identifies Key Molecular Interactions Responsible for the Effectiveness of the ZMapp™ Anti-Ebola Virus Cocktail

To support the creation of Ebola virus vaccines and treatments, Integral Molecular, a leader in membrane protein antibody discovery, has identified the key molecular interactions that […]
October 15, 2015

Integral Molecular Awarded $5.5M by the National Institutes of Health to Study Ebola Antibodies to Aid in Vaccine Discovery

With a new $5.5M award from the National Institute of Allergy and Infectious Diseases (NIAID) part of the National Institutes of Health (NIH), Integral Molecular, Inc. […]
July 3, 2015

Cat Got Your Tongue? Not According to New Research

The ability to detect bitter chemicals is thought to have evolved because it helps animals avoid toxic compounds often found in plants. All cats, from pets […]
December 10, 2014

Integral Molecular Identifies Potent Inhibitory Antibodies Against Chikungunya Virus

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a leader in membrane protein antibody discovery, in conjunction with Blood Systems Research Institute (BSRI), has identified potent inhibitory human antibodies against the […]
November 13, 2014

Integral Molecular Awarded $3.5M Contract from NIH to Study Ebola and Hepatitis C Virus Antibody Response

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, Inc. has been awarded a five year $3.5 million contract to study the human immune response to Ebola virus and hepatitis C virus […]
July 17, 2014

Integral Molecular Announces Patent Allowance for Dengue Research Technology

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a leader in membrane protein research, announces the issuance of a new composition patent protecting dengue reporter virus particles (RVPs). The invention relates […]
March 28, 2014

Integral Molecular Announces Patent Protecting the Use of Lipoparticles for Antibody Discovery

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a leader in membrane protein antibody discovery, announces the issuance of a new patent protecting the use of Lipoparticles for eliciting antibodies against […]
December 11, 2013

Integral Molecular Identifies Potent Antibody Antagonists Against Ion Channel Pain Target P2X3

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a leader in membrane protein antibody discovery, announces that it has successfully generated potent antibody antagonists targeting the P2X3 ion channel using the […]
November 6, 2013

Integral Molecular Announces Issuance of Third Patent Family, Extending Patent Landscape for Key Lipoparticle Technology

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a leader in membrane protein antibody discovery, announces the issuance of a new patent and patent family protecting the composition of matter for […]
April 22, 2013

Integral Molecular Launches MPS Platform for Discovery of Antibodies Targeting Membrane Proteins

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, Inc., a leader in membrane protein reagents and services, announces the launch of its Membrane Protein Solutions (MPS) antibody discovery platform. MPS enables […]
February 20, 2013

Patent for Nano-scale Detection of Ion Channel Function in Lipoparticles

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, Inc., a leader in membrane protein reagents and services, announces a patent allowance covering its technology for cell-free detection of ion channel function. […]
December 3, 2012

Integral Molecular and IntelliCyt Corporation Announce Co-marketing Collaboration

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular and IntelliCyt Corporation today announced the formation of a collaborative marketing alliance to co-promote Integral’s Shotgun Mutagenesis protein mapping and engineering platform and […]
November 15, 2012

Integral Molecular and Crystal Bioscience Announce Research Collaboration to Develop Novel GPCR and Ion Channel Antibodies

PHILADELPHIA–(BUSINESS WIRE)–Crystal Bioscience and Integral Molecular have launched a research collaboration to generate panels of chicken monoclonal antibodies against undisclosed therapeutic GPCR and ion channel targets. […]
May 3, 2012

Integral Molecular Announces Patent Allowance for its Membrane Protein Lipoparticle Technology

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a leader in membrane protein reagents and services, announces the issuance of a key patent protecting its methodology for generating Lipoparticles, which provide […]
April 25, 2012

Integral Molecular Announces Lipoparticle Distribution in Japan by Funakoshi

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a leader in membrane protein reagents and services, announces an exclusive agreement with Funakoshi for the distribution of Integral Molecular’s catalog of concentrated […]